Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Virios Therapeutics Inc.

    NASDAQ: VIRI · Real-Time Price · USD
    0.15
    0.01 (8.77%)
    At close: Oct 08, 2024, 10:00 PM

    Virios Therapeutics Statistics

    Share Statistics

    Virios Therapeutics has 1.33M shares outstanding. The number of shares has increased by -95.2% in one year.

    Shares Outstanding

    n/a
    		 1.33M

    Shares Change (YoY)

    n/a
    		 -95.2%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 5.12%

    Shares Floating

    n/a
    		 1.04M

    Failed to Deliver (FTD) Shares

    n/a
    		 12,075

    FTD / Avg. Volume

    n/a
    		 13.75%

    Short Selling Information

    Short Interest

    n/a
    		 n/a

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 n/a

    Short Ratio (days to cover)

    n/a
    		 n/a

    Valuation Ratios

    The PE ratio is -50.98 and the forward PE ratio is null. Virios Therapeutics's PEG ratio is 0.68.

    PE Ratio

    n/a
    		 -50.98

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 70.92

    P/FCF Ratio

    n/a
    		 -55.44

    PEG Ratio

    n/a
    		 0.68
    Financial Ratio History

    Enterprise Valuation

    Virios Therapeutics has an Enterprise Value (EV) of 266.68M.

    EV / Sales

    n/a
    		 0

    EV / EBITDA

    n/a
    		 1767.23

    EV / EBIT

    n/a
    		 -54.75

    EV / FCF

    n/a
    		 -54.75

    Financial Position

    The company has a current ratio of 11.62, with a Debt / Equity ratio of 0.

    Current Ratio

    n/a
    		 11.62

    Quick Ratio

    n/a
    		 11.62

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 n/a

    Debt / FCF

    n/a
    		 n/a

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is -139.12% and Return on Invested Capital is -142.93%.

    Return on Equity

    n/a
    		 -139.12%

    Return on Assets

    n/a
    		 -127.14%

    Return on Invested Capital

    n/a
    		 -142.93%

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-1,324,003.75

    Employee Count

    n/a
    		 4

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 -5.45K

    Effective Tax Rate

    n/a
    		 0.1%

    Stock Price Statistics

    The stock price has increased by -98.59% in the last 52 weeks. The beta is 1.58, so Virios Therapeutics's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.58

    52-Week Price Change

    n/a
    		 -98.59%

    50-Day Moving Average

    n/a
    		 4.41

    200-Day Moving Average

    n/a
    		 7.21

    Relative Strength Index (RSI)

    n/a
    		 51.55

    Average Volume (20 Days)

    n/a
    		 87,787

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -5.45M

    Net Income

    n/a
    		 -5.3M

    EBITDA

    n/a
    		 150.9K

    EBIT

    n/a
    		 n/a

    Earnings Per Share (EPS)

    n/a
    		 -0.28
    Full Income Statement

    Balance Sheet

    The company has 3.32M in cash and 0 in debt, giving a net cash position of 3.32M.

    Cash & Cash Equivalents

    n/a
    		 3.32M

    Total Debt

    n/a
    		 n/a

    Net Cash

    n/a
    		 n/a

    Retained Earnings

    n/a
    		 -61.47M

    Total Assets

    n/a
    		 3.64M

    Working Capital

    n/a
    		 3.14M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -4.87M and capital expenditures 0, giving a free cash flow of -4.87M.

    Operating Cash Flow

    n/a
    		 -4.87M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -4.87M

    FCF Per Share

    n/a
    		 -0.26
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    VIRI does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 -1.96%

    FCF Yield

    n/a
    		 -1.8%
    Dividend Details

    Analyst Forecast

    The average price target for VIRI is $15, which is 9900% higher than the current price. The consensus rating is "Hold".

    Price Target

    n/a
    		 $15

    Price Target Difference

    n/a
    		 9900%

    Analyst Consensus

    n/a
    		 Hold

    Analyst Count

    n/a
    		 2
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -29.81

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist